SAN FRANCISCO -- Progression-free survival (PFS) in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) more than doubled with the addition of the somatostatin analog (SSA) lanreotide (Somatuline ...
Enzastaurin (ENZ) before and concomitant with radiation therapy (RTX) followed by ENZ maintenance therapy in patients with newly diagnosed glioblastoma (GBM) without hypermethylation of the ...
Pieter Sonneveld, MD, PhD, chair of the Erasmus MC Cancer Institute, discussed the findings of a study modeling long-term progression-free survival (PFS) in patients with multiple myeloma (MM) treated ...
A phase II study of pomegranate extract for men with rising prostate-specific antigen following primary therapy. Background: Comparative effectiveness of the gonadotropin-releasing hormone (GnRH) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback